Rapid Reduction in use of antidiabetic medication after laparoscopic sleeve gastrectomy: The Newfoundland and Labrador bariatric surgery cohort (BaSCo) study

Canadian Journal of Hospital Pharmacy

Volumn 68, Issue 2, 2015, Pages 113-120

  Dillon, Carla ^a,b   Peddle, Justin ^a,b   Twells, Laurie ^a,b   Lester, Kendra ^b   Midodzi, William ^b   Manning, Kimberley ^c   Murphy, Raleen ^c   Pace, David ^b,c   Smith, Chris ^b,c   Boone, Darrell ^b,c   Gregory, Deborah ^b,c  

^a Health Sciences Centre St John's   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c Eastern Health Canada   (Canada)

Author keywords

Antihypertensive agents; Bariatric surgery; Drug utilization; Hypoglycemic agents; Hypolipidemic agents; Obesity

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN;

ADULT; ARTICLE; BARIATRIC SURGERY; BOUGIE; CANADA; COHORT ANALYSIS; COMORBIDITY; DYSLIPIDEMIA; ENDOSCOPIC ACCESSORY; FEMALE; GASTROINTESTINAL STAPLER; HUMAN; HYPERTENSION; LAPAROSCOPIC SLEEVE GASTRECTOMY; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE PRACTITIONER; OBESITY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; SLEEVE GASTRECTOMY; SURGICAL TECHNIQUE;

EID: 84957973346     PISSN: 00084123     EISSN: 19202903     Source Type: Journal    
DOI: 10.4212/cjhp.v68i2.1436     Document Type: Article

References (63)

1. Body mass index (BMI) nomogram. In: Canadian guidelines for body weight classification in adults. Ottawa (ON): Health Canada; 2003 [modified 2012 Feb 23; cited 2014 Jun 21]. Available from: www.hcsc. gc.ca/fn-an/nutrition/weights-poids/guide-ld-adult/bmi-chart-javagraph-imc-java-eng.php
2. Obesity in Canada: A joint report from the Public Health Agency of Canada and the Canadian Institute for Health Information. Ottawa (ON): Public Health Agency of Canada and Canadian Institute for Health Information; 2011 [cited 2014 Jun 21]. Available from: https://secure.cihi.ca/free-products/Obesity-in-canada-2011-en.pdf
3. Prospective Studies Collaboration, Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083-96.
4. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003;289(2):187-93.
5. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health. 2009;9:88.
6. Luo W, Morrison H, de Groh M, Waters C, DesMeules M, Jones-McLean E, et al. The burden of adult obesity in Canada. Chronic Dis Can. 2007; 27(4):135-44.
7. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004; 89(6):25839.
8. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999; 282(16):1523-9.
9. Tarride JE, Haq M, Taylor VH, Sharma AM, Nakhai-Pour HR, O'Reilly D, et al. Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada. Clinicoecon Outcomes Res. 2012;4:21-30.
10. de Hollander EL, Picavet HS, Milder IE, Verschuren WM, Bemelmans WJ, de Groot LC. The impact of long-term body mass index patterns on healthrelated quality of life: The Doetinchem Cohort Study. Am J Epidemiol. 2013;178(5):804-12.
11. Keating CL, Peeters A, Swinburn BA, Magliano DJ, Moodie ML. Utilitybased quality of life associated with overweight and obesity: The Australian diabetes, obesity, and lifestyle study. Obesity (Silver Spring). 2013;21(3):652-5.
12. Taylor VH, Forhan M, Vigod SN, McIntyre RS, Morrison KM. The impact of obesity on quality of life. Best Pract Res Clin Endocrinol Metab. 2013; 27(2):139-46.
13. Jia H, Lubetkin EI. The impact of obesity on health-related quality-oflife in the general adult US population. J Public Health (Oxf). 2005; 27(2):156-64.
14. McLaren L. Socioeconomic status and obesity. Epidemiol Rev. 2007;29:29-48.
15. Puhl RM, Heuer CA. The stigma of obesity: A review and update. Obesity (Silver Spring). 2009;17(5):941-64.
16. Howard JT, Potter LB. An assessment of the relationships between overweight, obesity, related chronic health conditions and worker absenteeism. Obes Res Clin Pract. 2014;8(1):e1-15.
17. Klarenbach S, Padwal R, Chuck A, Jacobs P. Population-based analysis of obesity and workforce participation. Obesity (Silver Spring). 2006; 14(5):920-7.
18. Neovius K, Johansson K, Rössner S, Neovius M. Disability pension, employment and obesity status: A systematic review. Obes Rev. 2008; 9(6):572-81.
19. van Duijvenbode DC, Hoozemans MJM, van Poppel MN, Proper KI. The relationship between overweight and obesity, and sick leave: A systematic review. Int J Obes (Lond). 2009;33(8):807-16.
20. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L; NEDCOM, Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Obesity in adulthood and its consequences for life expectancy: A life-table analysis. Ann Intern Med. 2003;138(1):24-32.
21. Allison DB, Fontaine KR, Manson JE, Stevens J, Vanltallie TB. Annual deaths attributable to obesity in the United States. JAMA. 1999; 282(16):1530-8.
22. Twells LK, Bridger T, Knight JC, Alaghehbandan R, Barrett B. Obesity predicts primary health care visits: A cohort study. Popul Health Manag. 2012;15(1):29-36.
23. Katzmarzyk PT, Ardern CI. Overweight and obesity mortality trends in Canada, 1985- 2000. Can J Public Health. 2004;95(1):16-20.
24. Twells LK, Gregory DM, Reddigan J, Midodzi WK. Current and predicted prevalence of obesity in Canada: A trend analysis. CMAJ Open. 2012 [cited 2014 Sep 22];2(1):E18-26. Available from: http://cmajopen.ca/content/ 2/1/E18.full
25. Canadian Health Measures Survey: cycle 2 data tables, 2009 to 2011. Ottawa (ON): Statistics Canada, Health Statistics Division; 2013 [modified 2013 Apr 17; cited 2014 Nov 30]. Available from: www.statcan.gc.ca/ pub/82-626-x/82-626-x2013001-eng.htm
26. Moffatt E, Shack LG, Petz GJ, Sauvé JK, Hayward K, Colman R. The cost of obesity and overweight in 2005: A case study of Alberta, Canada. Can J Public Health. 2011;102(2):144-8.
27. Lau DC; Obesity Canada Clinical Practice Guidelines Steering Committee and Expert Panel. Synopsis of the 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children. CMAJ. 2007;176(8):1103-6.
28. Wharton S, Sharma AM, Lau DC. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada: weight management in diabetes. Can J Diabetes. 2013;37 Suppl 1:S82-6. Available from: http://guidelines.diabetes.ca/fullguidelines/ Chapter17
29. Schirmer B, Schauer PR. Chapter 27. The surgical management of obesity. In: Brunicardi F, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Matthews JB, et al., editors. Schwartz's principles of surgery. 9th ed. New York (NY): McGraw-Hill; 2010 [cited 2015 Mar 26]. Available from: http:// accessmedicine.mhmedical.com/content.aspx?bookid=352&Sectionid= 40039769
30. Bariatric surgery in Canada. Ottawa (ON): Canadian Institute for Health Information; 2014 May [cited 2014 Jun 21]. Available from: https:// secure.cihi.ca/free-products/Bariatric-Surgery-in-Canada-EN.pdf
31. Arkinson J, Ji H, Fallah S, Pérez J, Chen XK, Leeb K. Bariatric surgery in Canada: A focus on day surgery procedures. Healthc Q. 2010;13(3):15-8.
32. Regan JP, Inabnet WB, Gagner M, Pomp A. Early experience with twostage laparoscopic Roux-en-Y gastric bypass as an alternative in the supersuper obese patient. Obes Surg. 2003;13(6):861-4.
33. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427-36.
34. Padwal R, Klarenbach S, Wiebe N, Hazel M, Birch D, Karmali S, et al. Bariatric surgery: A systematic review of the clinical and economic evidence. J Gen Intern Med. 2011;26(10):1183-94.
35. Trastulli S, Desiderio J, Guarino S, Cirocchi R, Scalercio V, Noya G, et al. Laparoscopic sleeve gastrectomy compared with other bariatric surgical procedures: A systematic review of randomized trials. Surg Obes Relat Dis. 2013;9(5):816-29.
36. Himpens J, Dapri G, Cadière GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16(11):1450-6.
37. Carlin AM, Zeni TM, English WJ, Hawasli AA, Genaw JA, Krause KR, et al; Michigan Bariatric Surgery Collaborative. The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity. Ann Surg. 2013;257(5):791-7.
38. Via MA, Mechanick JI. The role of bariatric surgery in the treatment of type 2 diabetes: current evidence and clinical guidelines. Curr Atheroscler Rep. 2013;15(11):366.
39. Anderson B, Switzer NJ, Almamar A, Shi X, Birch DW, Karmali S. The impact of laparoscopic sleeve gastrectomy on plasma ghrelin levels: A systematic review. Obes Surg. 2013;23(9):1476-80.
40. Bariatric surgery for obese patients with co-morbidities: A review of clinical effectiveness, cost-effectiveness, and guidelines. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2013 Aug 8 [cited 2014 Jun 21]. Available from: www.cadth.ca/media/pdf/htis/aug-2013/RC0468% 20Bariatric%20Surgery%20Final.pdf
41. Neovius M, Narbro K, Keating C, Peltonen M, Sjöholm K, Agren G, et al. Health care use during 20 years following bariatric surgery. JAMA. 2012;308(11):1132-41.
42. Jacobs M, Bisland W, Gomez E, Plasencia G, Mederos R, Celaya C, et al. Laparoscopic sleeve gastrectomy: A retrospective review of 1- and 2-year results. Surg Endosc. 2010;24(4):781-5.
43. Leonetti F, Capoccia D, Coccia F, Casella G, Baglio G, Paradiso F, et al. Obesity, type 2 diabetes mellitus, and other comorbidities: A prospective cohort study of laparoscopic sleeve gastrectomy vs medical treatment. Arch Surg. 2012;147(8):694-700.
44. Saul D, Stephens D, Hofstätter Rde C, Ahmed L, Langhoff E, Heimann TM. Preliminary outcomes of laparoscopic sleeve gastrectomy in a Veterans Affairs medical center. Am J Surg. 2012;204(5):e1-6.
45. Slater BJ, Bellatorre N, Eisenberg D. Early postoperative outcomes and medication cost savings after laparoscopic sleeve gastrectomy in morbidly obese patients with type 2 diabetes. J Obes. 2011;2011:350523.
46. Gill RS, Birch DW, Shi X, Sharma AM, Karmali S. Sleeve gastrectomy and type 2 diabetes mellitus: A systematic review. Surg Obes Relat Dis. 2010; 6(6):707-13.
47. Yip S, Plank LD, Murphy R. Gastric bypass and sleeve gastrectomy for type 2 diabetes: A systematic review and meta-analysis of outcomes. Obes Surg. 2013;23(12):1994-2003.
48. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012:26;366(17):1567-76.
49. Goldenberg R, Punthakee Z. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada: definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes. 2013;37 Suppl 1:S8-11. Available from: http://guidelines.diabetes.ca/Browse/Chapter3
50. 1983 Metropolitan height and weight tables. Stat Bull Metrop Life Found. 1983;64(1):3-9.
51. Powers KA, Rehriq ST, Jones DB. Financial impact of obesity and bariatric surgery. Med Clin North Am. 2007;91(3):321-38.
52. Twisk JWR. Applied longitudinal data analysis for epidemiology: A practical guide. New York (NY): Cambridge University Press; 2003.
53. Padwal RS, Chang HJ, Klarenbach S, Sharma AM., Majunmdar SR. Characteristics of the population eligible for and receiving publicly funded bariatric surgery in Canada. Int J Equity Health. 2012;11:54.
54. Shah PS, Todkar JS, Shah SS. Effectiveness of laparoscopic sleeve gastrectomy on glycemic control in obese Indians with type 2 diabetes mellitus. Surg Obes Relat Dis. 2010;6(2):138-41.
55. Casella G, Abbatini F, Calì B, Capoccia D, Leonetti F, Basso N. Ten-year duration of type 2 diabetes as prognostic factor for remission after sleeve gastrectomy. Surg Obes Relat Dis. 2011;7(6):697-702.
56. Ruiz-Tovar J, Oller I, Tomas A, Llavero C, Arrovo A, Calero A, et al. Midterm impact of gleeve gastrectomy, calibrated with a 50-Fr bougie, on weight loss, glucose homeostatsis, lipid profiles, and comorbidities in morbidly obese patients. Am Surg. 2012;78(9):969-74.
57. Snow LL, Weinstein LS, Hannon JK, Lane DR, Ringold FG, Hansen PA, et al. The effect of Roux-en-Y gastric bypass on prescription drug costs. Obes Surg. 2004;14(8):1031-5.
58. Malone M, Alger-Mayer SA. Medication use patterns after gastric bypass surgery for weight management. Ann Pharmacother. 2005;39(4):637-42.
59. Makary MA, Clark JM, Shore AD, Magnuson TH, Richards T, Bass EB, et al. Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery. Arch Surg. 2010; 145(8):726-31.
60. Quidley AM, Bland CM, Bookstaver PB, Kuper K. Perioperative management of bariatric surgery patients. Am J Health Syst Pharm. 2014; 71:1253-64.
61. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000 [cited 2014 Sep 22];894:i-xii, 1-253. Available from: www.who. int/nutrition/publications/obesity/WHO-TRS-894/en/
62. de Gordejuela AG, Pujol Gebelli J, García NV, Alsina EF, Medayo LS, Masdevall Noguera C. Is sleeve gastrectomy as effective as gastric bypass for remission of type 2 diabetes in morbidly obese patients? Surg Obes Relat Dis. 2011;7(4):506-9.
63. Vidal J, Ibarzabal A, Romero F, Delgado S, Momblán D, Flores L, et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg. 2008;18(9):1077-82.